… National LymphoCare Study, suggests that patients with early treatment failure undergoing
early autologous SCT had higher 5-year OS than those without auto SCT (73% vs 60%).133 …

… early treatment with either chemotherapy or rituximab alone. For patients needing therapy,
most patients are treated … No difference in time to treatment failure, histologic transformation, …

… to establish which gene signatures were enriched for treatment failure and poor PFS. A
23-gene predictor characterized by the presence of B-cell centroblasts was implicated in greater …

… Another aim of this study was to provide treating physicians with additional biomarkers
predictive of high-risk patients that might permit identification for early treatment intervention. …

… After a median follow-up of almost 4 years, time to treatment failure was similar at 3.9 and
3.6 … Treatment of early stage nodal follicular lymphoma using involved-field radiotherapy and …

… Few studies have reviewed FL treatments beyond the first-line setting. Treatment patterns
and outcomes of patients with early disease progression have also not been extensively …

… Follicular lymphoma is a clearly defined type of malignant lymphoma. The many … in
survival or disease free survival rates for the three histologic subtypes of follicular lymphoma. …

… Follicular lymphoma (FL) represents the most common subtype of indolent non-Hodgkin
lymphoma … (TTTF), time to next treatment (TTNT), freedom from treatment failure (FFTF), freedom …

… B-cell lymphoma 19 to identify the time point of 12 months in follicular lymphoma and we …
a powerful prognostic tool in follicular lymphoma—superseding baseline FLIPI score. Most …

… In addition to the early treatment-related mortality (… follicular lymphoma and the large number
of treatment options make it difficult to define a precise role for dose intensification. An early …